​

Funding Round

Series A - PinkDx

Series A - PinkDx

Investment Firm

Overview

PinkDx is a biotechnology company.

Announced Date

Apr 25, 2024

Funding Type

Series A

Highlights

Location

United States, North America

Social

Investor Lead

Catalio Capital Management

Catalio Capital Management

Catalio Capital Management is a debt and early_stage_venture and late_stage_venture and post_ipo and seed and venture firm.

The Production Board (TPB)

The Production Board (TPB)

The Production Board (TPB) is a early_stage_venture and seed firm.

Participant Investors

5

Investor Name
Participant InvestorLP Venture Group
Participant InvestorThe Production Board (TPB)
Participant InvestorCatalio Capital Management
Participant InvestorMountain Group Capital
Participant InvestorMayo Clinic

Round Details and Background

PinkDx raised $40000000 on 2024-04-25 in Series A

PinkDx is a biotechnology company.

Company Funding History

2

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Oct 20, 2023
Venture Round - PinkDx
-17.0M
Apr 25, 2024
Series A - PinkDx
6-40.0M

Recent Activity

There is no recent news or activity for this profile.